• Abbott lab: Morningstar upgrades to buy from hold with a target price of USD 104.
  • Abrdn plc: Numis downgrades to hold from add with a price target reduced from GBX 184 to GBX 167.
  • Amgen inc: BMO Capital Markets maintains its market perform recommendation with a price target raised from USD 260 to USD 286.
  • Best Buy: Goldman Sachs upgrades to buy from neutral. PT up 21% to $85.
  • Biogen inc: BMO Capital Markets maintains its outperform rating and reduces the target price from USD 336 to USD 314
  • Bristol-myer: BMO Capital Markets maintains its outperform rating and reduces the target price from USD 79 to USD 70.
  • Crowdstrike: Jefferies upgrades to buy from hold with a price target raised from USD 170 to USD 225.
  • Easyjet plc: Barclays downgrades to equalweight from overweight with a price target reduced from GBP 5.50 to GBP 4.15.
  • Eli lilly: BMO Capital Markets maintains its outperform recommendation and raises the target price from USD 633 to USD 710.
  • Fidelity nationa: Barclays upgrades to overweight from equalweight with a price target raised from USD 62 to USD 69.
  • First solar: JP Morgan upgrades to overweight from neutral with a price target reduced from USD 239 to USD 220.
  • Fortinet: Jefferies downgrades to hold from buy with a price target reduced from USD 85 to USD 65.
  • Foot Locker: Goldman Sachs downgrades to sell from neutral. PT down 18% to $18.
  • Incyte corp: BMO Capital Markets maintains its market perform recommendation with a price target reduced from USD 68 to USD 58.
  • Johnson & johnson: DZ Bank AG Research maintains its buy recommendation and reduces the target price from USD 186 to USD 182.
  • Lam research: Goldman Sachs maintains its buy recommendation and raises the target price from USD 684 to USD 700.
  • Lockheed martin: DZ Bank AG Research maintains its buy recommendation and reduces the target price from USD 570 to USD 550.
  • London stock ex: Goldman Sachs maintains its buy recommendation with a price target reduced from GBX 11100 to GBX 10900.
  • Man group: Barclays maintains its equalweight recommendation with a price target raised from GBP 2.75 to GBP 2.80.
  • McDonald's: RBC Capital maintains its outperform rating and reduces the target price from USD 340 to USD 315.
  • Microsoft corp: Citi maintains its buy recommendation with a price target raised from USD 420 to USD 430.
  • Nasdaq: Morningstar upgrades to buy from hold with a target price of USD 55.
  • Netflix: KeyBanc Capital Markets upgrades to overweight from sector weight with a target price of USD 510.
  • Pembina pipeline: CIBC Capital Markets upgrades to outperform from neutral with a price target reduced from CAD 53 to CAD 51.
  • Schroders plc: Panmure Gordon & Co. Limited maintains its hold recommendation with a price target reduced from GBX 430 to GBX 420.
  • Targa resources: Haitong International Research Ltd initiates its outperform recommendation with a target price of USD 116.95.
  • Tesla: Fubon Securities downgrades to neutral from buy with a price target reduced from USD 330 to USD 275.
  • Unity software i: Jefferies downgrades to hold from underperform with a price target reduced from USD 29 to USD 27.
  • Visa: Mizuho Securities maintains its neutral recommendation with a price target reduced from USD 255 to USD 240.
  • Xylem inc: Oppenheimer upgrades to outperform from market perform with a target price of USD 118.
  • Zscaler: Jefferies upgrades to buy from hold with a price target raised from USD 170 to USD 225.